{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:13:12Z","timestamp":1793214792780,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T00:00:00Z","timestamp":1110240000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Minimal (i.e. submicroscopic) residual disease (MRD) predicts outcome in childhood acute lymphoblastic leukaemia (ALL). To be used clinically, MRD assays must be reliable and accurate. Two well\u2010established techniques, flow cytometry (FC) and polymerase chain reaction (PCR), can detect leukaemic cells with a sensitivity of 0\u00b701% (10<jats:sup>\u22124<\/jats:sup>). We analysed diagnostic samples of 45 ALL\u2010patients (37 B\u2010lineage ALL, eight T\u2010lineage ALL) by four\u2010colour FC and real\u2010time PCR. Leukaemia\u2010associated immunophenotypes, at a sensitivity of MRD detection by FC at the 0\u00b701% level, were identified in 41 cases (91%); antigen\u2010receptor gene rearrangements suitable for MRD detection with a sensitivity of 0\u00b701% or better by PCR were identified in 38 cases (84%). The combined use of FC and PCR allowed MRD monitoring in all 45 patients. In 105 follow\u2010up samples, MRD estimates by both methods were highly concordant, with a deviation factor of &lt;5 by Bland\u2013Altman analysis. Importantly, the concordance between FC and PCR was also observed in regenerating bone marrow samples containing high proportions of CD19<jats:sup>+<\/jats:sup> cells, and in samples studied 24\u2003h after collection. We conclude that both MRD assays yield generally concordant results. Their combined use should enable MRD monitoring in virtually all patients and prevent false\u2010negative results due to clonal evolution or phenotypic shifts.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05401.x","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T13:03:16Z","timestamp":1110286996000},"page":"774-782","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real\u2010time PCR"],"prefix":"10.1111","volume":"128","author":[{"given":"Gunter","family":"Kerst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Kreyenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Well","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Coustan\u2010Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Koscielniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Niethammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,8]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402552"},{"key":"e_1_2_14_3_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02643.x"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401831"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990180203"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04393.x"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2002.0182"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(92)90100-C"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390904"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.7.2115"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10295-1"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2691"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1130"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/334395a0"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08570.x"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04058-6"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000090174"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009087020"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1952"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04394.x"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.11.4072"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704241"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1455"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402091"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403444"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401459"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403348"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1253"},{"key":"e_1_2_14_33_1","first-page":"1708","article-title":"Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions","volume":"45","author":"Orfao A.","year":"1999","journal-title":"Clinical Chemistry"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401246"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401245"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401780"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401973"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(00)00418-6"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402206"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402198"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402475"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402515"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402922"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401801"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4386"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05401.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05401.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:21:45Z","timestamp":1697379705000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05401.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05401.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05401.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2005-03-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}